It has been reported in the literature that the endogenous estrogen metabol
ite 2-methoxyestradiol (2-ME) inhibits both manganese and copper,zinc super
oxide dismutases (Mn and Cu,Zn SODs) and that this mechanism is responsible
for 2-ME's ability to kill cancer cells. In fact, as demonstrated using se
veral SOD assays including pulse radiolysis, 2-ME does not inhibit SOD but
rather interferes with the SOD assay originally used. Nevertheless, as conf
irmed by aconitase inactivation measurements and lactate dehydrogenase rele
ase in human leukemia HL-60 cells, 2-ME does increase superoxide production
in these cells and is more toxic than its non-O-methylated precursor 2-hyd
roxyestradiol. Other mechanisms previously suggested in the literature may
explain 2-ME's ability to increase intracellular superoxide levels in tumor
cells. (C) 2001 Academic Press.